War on carcinogens: Industry disputes human relevance of chemicals causing cancer in laboratory animals based on unproven hypotheses, using kidney tumors as an example

International Journal of Occupational and Environmental Health

Volumn 19, Issue 4, 2013, Pages 255-260

  Melnick, Ronald L ^a   Ward, Jerrold M ^b   Huff, James ^c  

^a Science Soft   (United States)

^b Global VetPathology   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Carcinogenicity; Chronic progressive nephropathy; Human relevance; Kidney; Rats; Renal tubule tumors; Risk assessment

Indexed keywords

CARCINOGEN;

ANIMAL; CHEMICAL INDUSTRY; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; EDITORIAL; EPIDEMIOLOGY; HUMAN; KIDNEY TUMOR; METHODOLOGY; ORGANIZATION AND MANAGEMENT; POLLUTANT;

ANIMALS; CARCINOGENS; CAUSALITY; CHEMICAL INDUSTRY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL POLLUTANTS; HUMANS; KIDNEY NEOPLASMS; RESEARCH DESIGN;

EID: 84886784328     PISSN: 10773525     EISSN: None     Source Type: Journal    
DOI: 10.1179/1077352513Z.00000000090     Document Type: Editorial

References (41)

1. Weisburger EK. History of the bioassay program of the National Cancer Institute. Prog Exp Tumor Res. 1983;26:187-201.
2. Huff J. The Legacy of David Platt Rall. Scientific, environ- mental, public health, and regulatory contributions. Eur J Oncol. 2000;5:85-100.
3. Huff J. David Rall and the national toxicology program. Environ Health Perspect. 2005;113:A152.
4. IARC. Tobacco Smoking, Secondhand Tobacco Smoke. Smokeless Tobacco in: Personal habits and indoor combustions. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt):1-318.
5. RoC/NTP. Tobacco-related exposures: smokeless tobacco, environmental tobacco smoke, tobacco smoking in: NTP Rep Carcinog. 2011;12:408-14.
6. Davis D. The Secret History of the War on Cancer 2007. New York:Basic Books, NY, 505 pp.
7. Epstein SS. The Politics of Cancer Revisited 1998. East Ridge Press, Fremont Center, NY, 770 pp.
8. Michaels D. Doubt is Their Product: How Industry's Assault on Science Threatens Your Health 2008. Oxford University Press, NY, 372 pp.
9. American Council on Science and Health. A summary of America's War on "Carcinogens": Reassessing the use of animal tests to predict human cancer risk. 2005. In: Whelan EM, Ross GL, Stimola AN, editors. 2005. Available at http://www.acsh.org/wp-content/uploads/2012/04/20050126_WOCSummary. pdf
10. Huff J. Industry influence on occupational and environmental public health. Int J Occup Environ Health. 2007;13:107-17.
11. Melnick RL, Kamel F, Huff J. Declaring chemicals not carcinogenic to humans requires validation, not speculation. Environ Health Perspect. 2003;111:A203-4.
12. Hard GC. Significance of the renal effects of ethyl benzene in rodents for assessing human carcinogenic risk. Toxicol Sci. 2002;69:30-41.
13. Hard GC, Khan KN. A contemporary overview of chronic progressive nephropathy in the laboratory rat, and its significance for human risk assessment. Toxicol Pathol. 2004;32:171-80.
14. Hard GC, Seely JC, Betz LJ, Hayashi SM. Re-evaluation of the kidney tumors and renal histopathology occurring in a 2-year rat carcinogenicity bioassay of quercetin. Food Chem Toxicol. 2007;45:600-8.
15. Hard GC, Johnson KJ, Cohen SM. A comparison of rat chronic progressive nephropathy with human renal disease-Implications for human risk assessment. Crit. Rev. Toxicol. 2009;39:332-46.
16. Hard GC, Bruner RH, Cohen SM, Pletcher JM, Regan KS. Renal histopathology in toxicity and carcinogenicity studies with tert-butyl alcohol administered in drinking water to F344 rats: a pathology working group review and re-evaluation. Regul Toxicol Pharmacol. 2011;59:430-6.
17. Travlos GS, Hard GC, Betz LJ, Kissling GE. Chronic progressive nephropathy in male F344 rats in 90-day toxicity studies: its occurrence and association with renal tubule tumors in subsequent 2-year bioassays. Toxicol Pathol. 2011;39:381-9.
18. Simard EP, Ward EM, Siegel R, Jemal A. Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin. 2012 Jan 4. doi: 10.3322/caac.20141. [Epub ahead of print]
19. Buzio L, Tondel M, De Palma G, Buzio io L, Tondel M, De Palma G, Buzio C, Franchini I, Mutti A, et al. Occupational risk factors for renal cell cancer. An Italian case-control study. Med Lav. 2002;93:303-9.
20. Huff J, Melnick R, Tomatis L, LaDou J, Teitelbaum D. Trichloroethylene and cancers in humans. Toxicology. 2004;197:185-7.
21. Kluwe WM, Abdo KM, Huff J. Chronic kidney disease and organic chemical exposures: evaluations of causal relationships in humans and experimental animals. Fundam Appl Toxicol. 1984;4:889-901.
22. Pesch B, Haerting J, Ranft U, Klimpel A, Oelschlägel B, Schill W. Occupational risk factors for renal cell carcinoma: agentspecific results from a case-control study in Germany. MURC Study Group. Multicenter urothelial and renal cancer study. Int J Epidemiol. 2000;29:1014-24.
23. United States Environmental Protection Agency (U.S. EPA). Toxicological review of trichloroethylene (CAS No. 79-01-6) 2011. EPA/635/R-09/011F. Available at http://www.epa.gov/ iris/supdocs/0199index.html
24. IARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Accessed July 2013. http://monographsiarc.fr/ENG/Monographs/PDFs/index.php
25. RoC/NTP. Report on Carcinogens. http://ntp.niehs.nih.gov/ntp/roc/twelfth/roc12.pdf Accessed July 2013
26. Bruner RH, Greaves P, Hard GC, Regan KS, Ward JM, David RM. Histopathologic changes in the kidneys of male F344 rats from a 2-year inhalation carcinogenicity study of tetrahydro- furan: a pathology working group review and re-evaluation. Regul Toxicol Pharmacol. 2010;58:100-5.
27. Hard GC, Seely JC. Recommendations for the interpretation of renal tubule proliferative lesions occurring in rat kidneys with advanced chronic progressive nephropathy (CPN). Toxicol Pathol. 2005;33:641-9.
28. Hard GC, Whysner J, English JC, Zang E, Williams GM. Relationship of hydroquinone-associated rat renal tumors with spontaneous chronic progressive nephropathy. Toxicol Pathol. 1997;25:132-43.
29. Dominick MA, Robertson DG, Bleavins MR, Sigler RE, Bobrowski WF, Gough AW. Alpha 2u-globulin nephropathy without nephrocarcinogenesis in male Wistar rats administered 1-(aminomethyl)cyclohexaneacetic acid. Toxicol Appl Pharmacol. 1991;111:375-87.
30. Malley LA, Kennedy GL, Elliott GS, Slone TW, Mellert W, Deckardt K, et al. Chronic toxicity and oncogenicity of N-methylpyrrolidone (NMP) in rats and mice by dietary admin- istration. Drug Chem Toxicol. 2001;24:315-38.
31. Malley LA, Slone TW Jr, Makovec GT, Elliott GS, Kennedy GL Jr. Chronic toxicity/oncogenicity of dimethylacetamide in rats and mice following inhalation exposure. Fundam Appl Toxicol. 1995;28:80-93.
32. Melnick RL, Burns KM, Ward JM, Huff J. Chemically exacerbated chronic progressive nephropathy not associated with renal tubular tumor induction in rats: an evaluation based on 60 carcinogenicity studies by the national toxicology program. Toxicol Sci. 2012;128:346-56.
33. Hard GC, Banton MI, Bretzlaff RS, Dekant W, Fowles JR, Mallett AK, et al. Consideration of rat chronic progressive nephropathy in regulatory evaluations for carcinogenicity. Toxicol Sci. 2013;132:268-75. Advance Access published October 26, 2012. Doi:10.1093/toxsci/kfs305
34. United States Environmental Protection Agency (U.S. EPA). Guidelines for carcinogen risk assessment. 2005. EPA/630/P-03/001F. Available at http://www.epa.gov/cancerguidelines/.
35. Hill AP. The environment and disease: Association or causation? Proc R Soc Med 1965;58:295-300.
36. Tomatis L. The IARC monographs program: changing attitudes towards public health. Int J Occup Environ Health. 2002;8:144-52.
37. Axelson O, Castleman B, Epstein S, Franco G, Giannasi F, Grandjean P,et al. Re: Implementation of WHO Guidelines on Disclosure of Interest by members of WHO Expert Panels. Int J Occup Environ Health. 2002;8:271-3.
38. Axelson O, Balbus JM, Cohen G, Davis D, Donnay A, Doolittle R, et al. Re: Regulatory Toxicology and Pharmacology. Int J Occup Environ Health. 2003;9:386-9.
39. Huff J. IARC monographs, industry influence, and upgrading, downgrading, and under-grading chemicals: a personal point of view. International Agency for Research on Cancer. Int J Occup Environ Health. 2002;8:249-70.
40. Jacobson MF, Sharpe VA, Angell M, Ashford NA, Blum A, Chary LK, et al. Editorial policies on financial disclosure. Nat Neurosci. 2003;6:1001.
41. LaDou J, Teitelbaum DT, Egilman DS, Frank AL, Kramer SN, Huff J. American College of Occupational and Environmental Medicine (ACOEM): a professional association in service to industry. Int J Occup Environ Health. 2007;13:404-26.